Sarah B. Noonberg insider trades
Open-market stock purchases and sales by Sarah B. Noonberg, Director at Neurogene Inc, from SEC Form 4 filings since May 16, 2017.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Feb 20, 2026 | NGNE Neurogene Inc | Bought (not open market) | — |
Companies traded
- NGNE Neurogene Inc: other filings, last Feb 20, 2026
- MGX Metagenomi, Inc: 1 sale, last Jun 6, 2025
- MRNS Marinus Pharmaceuticals, Inc: other filings, last Jun 18, 2024
- NLTX Neoleukin Therapeutics, Inc: other filings, last Jun 8, 2023
- PTGX Protagonist Therapeutics, Inc: 3 sales, last Jan 16, 2023
- PRTA Prothena Corp plc: other filings, last May 16, 2017